HSP90AA1 and congenital bilateral aplasia of vas deferens from CFTR mutation: We confirmed this decrease in HSP90β protein levels in calcified valves by performing a Western blot analysis and then conducted an IPA analysis to predict HSP90 interactions in CAVD.